TRADE NEWS: Agilent Technologies Introduces SureSelect Strand-Specific RNA Library Preparation Kit

  TRADE NEWS: Agilent Technologies Introduces SureSelect Strand-Specific RNA
  Library Preparation Kit

   New Product Designed for Whole Transcriptome and Targeted RNA Sequencing

Business Wire

SANTA CLARA, Calif. -- February 20, 2013

Agilent Technologies Inc. (NYSE: A) today introduced the SureSelect
Strand-Specific RNA Library Preparation Kit for whole transcriptome and
targeted RNA sequencing.

The new kit enables researchers to prepare high-quality, strand-specific
libraries for next-generation sequencing. The ability to gain valuable
strand-specific information from RNA-sequencing experiments allows researchers
to more easily discern overlapping transcripts and investigate antisense
expression for greater understanding of gene regulation.

The kit has been optimized to provide outstanding sequencing performance and
uniform coverage of the entire transcript. This is achieved through greater
library complexity and less 5’/3’ bias, even with small amounts of starting
material (as low as 50 ng). The kit has also been designed to be as complete
as possible, including master-mixed reagents and a streamlined workflow for
less hands-on time and faster results.

“Strand-specific RNA-sequencing library preparation is the latest addition to
Agilent’s next-generation sequencing/gene-regulation portfolio, which offers
the most complete integrated solutions from sample to analysis,” said Yong Yi,
Agilent associate director of marketing for genomics. “We are thrilled to
provide another highly sensitive tool that will advance understanding of how
gene regulation governs normal and aberrant biological processes.”

Other key products in Agilent’s gene-regulation portfolio include SureSelect
human methyl-seq, targeted RNA-seq, gene expression and miRNA microarrays,
GeneSpring data analysis software, 2100 Bioanalyzer, and 2200 TapeStation.

About Agilent in Genomics

Agilent Technologies Inc. is a global leader in target enrichment for
next-generation sequencing and genomic microarrays. The Agilent SureSelect and
HaloPlex target-enrichment systems enable researchers to easily choose which
segments of a genome to sequence, avoiding the time and expense needed to
sequence the entire genome. HaloPlex and its same-day sample-to-sequencer
workflow is well suited for next-generation desktop sequencers, whereas
SureSelect’s ability to accurately capture whole exomes and whole methylomes
in a single reaction pairs well with high-throughput next-generation
sequencing systems. These are just two products arising from Agilent’s
expertise in synthesizing custom complex mixtures of long oligonucleotide
gained in microarray manufacturing. Additional product lines built on this
core technology include microarrays for genome-wide measurement of gene
expression and for comparative genomics hybridization, as well as SureFISH, a
highly specific and sensitive oligonucleotide fluorescent in situ
hybridization product line. In addition to oligonucleotide-based products,
Agilent offers a microfluidic bioanalyzer to measure sample quality, a
target-enrichment tool to speed next-generation sequencing, and a full set of
reagents, hardware, methods and bioinformatics software for genomic
experiments.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company
and a technology leader in chemical analysis, life sciences, diagnostics,
electronics and communications. The company’s 20,500 employees serve customers
in more than 100 countries. Agilent had revenues of $6.9 billion in fiscal
2012. Information about Agilent is available at www.agilent.com.

NOTE TO EDITORS: Further technology, corporate citizenship and executive news
are available at www.agilent.com/go/news.

Contact:

Agilent Technologies Inc.
Eric Endicott, +1 408-553-2005
eric_endicott@agilent.com